Fate Therapeutics Inc SEC filings FATE
Fate Therapeutics Inc has 855 filings in SEC EDGAR's recent list, going back to May 2, 2008. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, agreement ended). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 3, 2026 |
| 144 | Notice of proposed sale | Nov 3, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 28, 2026 | Sep 25, 2026 |
| S-8 | Employee stock plan registration | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 4, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 4, 2026 |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 12, 2026 |
| 3 | Initial insider ownership | Jun 15, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 15, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Other events
|
Jun 4, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 20, 2026 |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 6, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 12, 2026 |
| 4/A | Ownership document | Apr 23, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 20, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 22, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 15, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 15, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 15, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 9, 2026 |
| 144 | Notice of proposed sale | Jan 9, 2026 | — |
| 144 | Notice of proposed sale | Jan 9, 2026 | — |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 27, 2025 | Oct 26, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 20, 2025 |
| 3 | Initial insider ownership | Oct 21, 2025 | Oct 20, 2025 |
| S-8 | Employee stock plan registration | Oct 20, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 14, 2025 | Oct 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Aug 12, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 4, 2025 |
| 4 | Insider transaction | Aug 5, 2025 | Aug 4, 2025 |
| 144 | Notice of proposed sale | Aug 4, 2025 | — |
| 144 | Notice of proposed sale | Aug 4, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| 3 | Initial insider ownership | Jul 3, 2025 | Jul 2, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 3, 2025 | — |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jun 17, 2025 | May 29, 2025 |
| S-8 | Employee stock plan registration | Jun 4, 2025 | — |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 29, 2025 |
| 3 | Initial insider ownership | May 30, 2025 | May 29, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 9, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2025 | — |
| ARS | Annual report to shareholders | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 17, 2025 | — |
| DEF 14A | Proxy statement | Apr 17, 2025 | May 29, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 7, 2025 | May 29, 2025 |
| 144 | Notice of proposed sale | Mar 6, 2025 | — |
| 10-K | Annual report | Mar 5, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2025 | Mar 5, 2025 |
| 4 | Insider transaction | Jan 16, 2025 | Jan 16, 2025 |
| 4 | Insider transaction | Jan 16, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 16, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 10, 2025 |
| 144 | Notice of proposed sale | Jan 10, 2025 | — |
| 144 | Notice of proposed sale | Jan 10, 2025 | — |
| 144 | Notice of proposed sale | Jan 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 6, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Dec 26, 2024 | Dec 20, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 26, 2024 | — |
| 144 | Notice of proposed sale | Dec 20, 2024 | — |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Nov 29, 2024 | Nov 27, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 25, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 21, 2024 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Aug 30, 2024 | Aug 26, 2024 |
| 3 | Initial insider ownership | Aug 21, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Aug 7, 2024 | Aug 6, 2024 |
| 144 | Notice of proposed sale | Aug 6, 2024 | — |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| 3 | Initial insider ownership | Jul 31, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 31, 2024 | Jul 29, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 11, 2024 | Jun 7, 2024 |
| S-8 | Employee stock plan registration | Jun 10, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 10, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Officer or director change
|
May 31, 2024 | May 30, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 9, 2024 | May 9, 2024 |
| 424B3 | Prospectus | May 2, 2024 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 7, 2024 |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| S-3 | Shelf registration | Apr 18, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 25, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 21, 2024 | Mar 19, 2024 |
| 424B5 | Prospectus supplement | Mar 20, 2024 | — |
| 4 | Insider transaction | Mar 5, 2024 | Mar 4, 2024 |
| 144 | Notice of proposed sale | Mar 4, 2024 | — |
| 10-K | Annual report | Feb 26, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2024 | Feb 26, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Jan 30, 2024 | Jan 29, 2024 |
| 144 | Notice of proposed sale | Jan 29, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 25, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 22, 2024 | — |
| 4 | Insider transaction | Jan 10, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 10, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 10, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 10, 2024 | Jan 9, 2024 |
| 144 | Notice of proposed sale | Jan 9, 2024 | — |
| 144 | Notice of proposed sale | Jan 9, 2024 | — |
| 144 | Notice of proposed sale | Jan 9, 2024 | — |
| 144 | Notice of proposed sale | Jan 9, 2024 | — |
| 4 | Insider transaction | Jan 3, 2024 | Jan 2, 2024 |
| 144 | Notice of proposed sale | Jan 2, 2024 | — |
| 4 | Insider transaction | Dec 28, 2023 | Dec 26, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 28, 2023 | — |
| 4 | Insider transaction | Dec 19, 2023 | Dec 18, 2023 |
| 144 | Notice of proposed sale | Dec 18, 2023 | — |
| EFFECT | Filing | Nov 27, 2023 | — |
| CORRESP | Letter to the SEC | Nov 21, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2023 | — |
| 4 | Insider transaction | Nov 13, 2023 | Nov 9, 2023 |
| 144 | Notice of proposed sale | Nov 9, 2023 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 8, 2023 | Nov 8, 2023 |
| S-3 | Shelf registration | Nov 8, 2023 | — |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 10, 2023 | — |
| 8-K |
Current report
Other events
|
Sep 1, 2023 | Aug 30, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- FATE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1434316
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.